دورية أكاديمية

Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: a prospective cohort study.

التفاصيل البيبلوغرافية
العنوان: Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: a prospective cohort study.
المؤلفون: Kunutsor SK; Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4WP, UK. skk31@cantab.net., Seidu S; Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4WP, UK., Kurl S; Department of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland., Laukkanen JA; Department of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.; Wellbeing Services County of Central Finland, Department of Medicine, Jyväskylä, Finland.
المصدر: GeroScience [Geroscience] 2024 Jun; Vol. 46 (3), pp. 3035-3046. Date of Electronic Publication: 2024 Jan 05.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Cham : Springer International Publishing, [2017]-
مواضيع طبية MeSH: Diabetes Mellitus, Type 2* , Renal Insufficiency, Chronic*/epidemiology, Male ; Humans ; Prospective Studies ; Glucose ; Triglycerides ; Blood Glucose/analysis
مستخلص: Triglyceride-glucose (TyG) index is an emerging marker of adverse cardiometabolic conditions such as cardiovascular disease and type 2 diabetes. The long-term relevance of TyG index to chronic kidney disease (CKD) is uncertain. We aimed to assess the association of TyG index with CKD risk and its utility in risk prediction in a prospective study. The TyG index was calculated using fasting triglycerides and fasting plasma glucose (FPG) levels measured in 2362 men aged 42-61 years with normal kidney function using the formula: Ln (fasting triglycerides [mg/dL] × FPG [mg/dL]/2). Multivariable adjusted hazard ratios (HRs) (95% confidence intervals, CIs) were estimated for CKD. Correction for within-person variability was made using data from repeat measurements of triglycerides and FPG taken 11 years after baseline. Over a median follow-up duration of 17.5 years, 223 CKD cases were recorded. The age-adjusted regression dilution ratio for the TyG index was 0.54 (95% CI, 0.48-0.60). The risk of CKD increased continuously with increasing TyG index across the range 9.3 to 11.6 (p value for nonlinearity<.001). In analysis adjusted for established risk factors, a unit higher TyG index was associated with an increased risk of CKD (HR 1.59, 95% CI 1.24-2.05). Comparing extreme tertiles of the TyG index, the corresponding adjusted HR (95% CI) for CKD was 1.61 (1.15-2.27). Addition of the TyG index to a CKD risk prediction model containing established risk factors improved risk discrimination and reclassification (p value for difference in -2 log likelihood<.001; NRI=47.66%, p=.014; IDI=0.0164, p<.001). Higher TyG index is associated with an increased risk of CKD and improves the prediction and classification of CKD beyond established risk factors. Using single baseline estimations of the TyG index to investigate its association with CKD risk could considerably under-estimate the true association.
(© 2024. The Author(s).)
References: World Health Organization. Fact sheets. The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death . Retrieved on 10 Sep 2021.
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70. https://doi.org/10.1038/ki.2011.368 . (PMID: 10.1038/ki.2011.36821993585)
Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2015;66(1 Suppl 1):S1–305. https://doi.org/10.1053/j.ajkd.2015.05.001 . (PMID: 10.1053/j.ajkd.2015.05.001)
Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16(7):2134–40. https://doi.org/10.1681/ASN.2005010106 . (PMID: 10.1681/ASN.200501010615901764)
Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51. https://doi.org/10.1210/jc.2010-0288 . (PMID: 10.1210/jc.2010-028820484475)
Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. https://doi.org/10.1089/met.2008.0034 . (PMID: 10.1089/met.2008.003419067533)
Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum A, Barbarash O, Chifamba J, Diaz ML, Gulec S, Ismail N, Iqbal R, Kelishadi R, Khatib R, Lanas F, Levitt NS, Li Y, Mohan V, Mony PK, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23–33. https://doi.org/10.1016/S2666-7568(22)00247-1 . (PMID: 10.1016/S2666-7568(22)00247-136521498)
Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. https://doi.org/10.1186/s12933-021-01268-9 . (PMID: 10.1186/s12933-021-01268-9338123738019501)
da Silva A, Caldas APS, Rocha D, Bressan J. Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk: a systematic review and meta-analysis of cohort studies. Prim Care Diabetes. 2020;14(6):584–93. https://doi.org/10.1016/j.pcd.2020.09.001 . (PMID: 10.1016/j.pcd.2020.09.00132928692)
Son DH, Lee HS, Lee YJ, Lee JH, Han JH. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022;32(3):596–604. https://doi.org/10.1016/j.numecd.2021.11.017 . (PMID: 10.1016/j.numecd.2021.11.01735090800)
Wang C, Li F, Guo J, Li C, Xu D, Wang B. Insulin resistance, blood glucose and inflammatory cytokine levels are risk factors for cardiovascular events in diabetic patients complicated with coronary heart disease. Exp Ther Med. 2018;15(2):1515–9. https://doi.org/10.3892/etm.2017.5584 . (PMID: 10.3892/etm.2017.558429434736)
Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis. 2005;45(2):275–80. https://doi.org/10.1053/j.ajkd.2004.09.034 . (PMID: 10.1053/j.ajkd.2004.09.03415685504)
Shi Y, Hu L, Li M, Zhou W, Wang T, Zhu L, Bao H, Cheng X, Li P. Association between the surrogate markers of insulin resistance and chronic kidney disease in Chinese hypertensive patients. Front Med (Lausanne). 2022;9:831648. https://doi.org/10.3389/fmed.2022.831648 . (PMID: 10.3389/fmed.2022.831648351985788859105)
Liu N, Liu C, Qu Z, Tan J. Association between the triglyceride-glucose index and chronic kidney disease in adults. Int Urol Nephrol. 2023;55(5):1279–89. https://doi.org/10.1007/s11255-022-03433-9 . (PMID: 10.1007/s11255-022-03433-936472799)
Low S, Pek S, Moh A, Ang K, Khoo J, Shao YM, Tang WE, Lim Z, Subramaniam T, Sum CF, Lim SC. Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes—mediation by pigment epithelium-derived factor. Diab Vasc Dis Res. 2022;19(4):14791641221113784. https://doi.org/10.1177/14791641221113784 . (PMID: 10.1177/14791641221113784359384909364218)
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765–74. (PMID: 10.1016/0140-6736(90)90878-91969518)
Kunutsor SK, Isiozor NM, Myers J, Seidu S, Khunti K, Laukkanen JA. Baseline and usual cardiorespiratory fitness and the risk of chronic kidney disease: a prospective study and meta-analysis of published observational cohort studies. Geroscience. 2023; https://doi.org/10.1007/s11357-023-00727-3 .
Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20(1-2):46–50. (PMID: 3408213)
Kunutsor SK, Laukkanen JA. Serum zinc concentrations and incident hypertension: new findings from a population-based cohort study. J Hypertens. 2016; https://doi.org/10.1097/HJH.0000000000000923 .
Kunutsor SK, Seidu S, Blom AW, Khunti K, Laukkanen JA. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence. Eur J Epidemiol. 2017;32(8):657–67. https://doi.org/10.1007/s10654-017-0277-4 . (PMID: 10.1007/s10654-017-0277-4287180295591345)
Salonen JT, Salonen R, Seppanen K, Rauramaa R, Tuomilehto J. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation. 1991;84(1):129–39. (PMID: 10.1161/01.CIR.84.1.1292060089)
Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86(3):803–11. (PMID: 10.1161/01.CIR.86.3.8031516192)
Kunutsor SK, Jae SY, Makikallio TH, Kurl S, Laukkanen JA. High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: a cohort study. Respir Med. 2021;189:106647. https://doi.org/10.1016/j.rmed.2021.106647 . (PMID: 10.1016/j.rmed.2021.10664734655960)
Kunutsor SK, Jae SY, Makikallio TH, Laukkanen JA. High fitness levels attenuate the increased risk of heart failure due to low socioeconomic status: a cohort study. Eur J Clin Invest. 2022:e13744. https://doi.org/10.1111/eci.13744 .
Kunutsor SK, Jae SY, Makikallio TH, Laukkanen JA. High fitness levels attenuate the increased risk of hypertension due to low socioeconomic status in middle-aged men: a cohort study. J Cardiopulm Rehabil Prev. 2022;42(2):134–6. https://doi.org/10.1097/HCR.0000000000000673 . (PMID: 10.1097/HCR.000000000000067335121703)
Laukkanen JA, Laaksonen D, Lakka TA, Savonen K, Rauramaa R, Makikallio T, Kurl S. Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol. 2009;103(11):1598–604. https://doi.org/10.1016/j.amjcard.2009.01.371 . (PMID: 10.1016/j.amjcard.2009.01.37119463522)
Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58(5):961–7. https://doi.org/10.1007/s00125-015-3520-0 . (PMID: 10.1007/s00125-015-3520-025680582)
National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
Kunutsor SK, Jae SY, Kauhanen J, Laukkanen JA. High fitness levels offset the increased risk of chronic kidney disease due to low socioeconomic status: a prospective study. Am J Med. 2022;135(10):1247–54. https://doi.org/10.1016/j.amjmed.2022.06.010 . (PMID: 10.1016/j.amjmed.2022.06.01035820458)
Kunutsor SK, Kurl S, Laukkanen JA. High fitness levels attenuate the increased risk of chronic kidney disease in men with high systolic blood pressure: a prospective cohort study. J Cardiopulm Rehabil Prev. 2023;43(4):311–3. https://doi.org/10.1097/HCR.0000000000000793 . (PMID: 10.1097/HCR.000000000000079337014995)
Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York, NY: Springer; 2000. p. 39–77. https://doi.org/10.1007/978-1-4757-3294-8&#95;3 . (PMID: 10.1007/978-1-4757-3294-8_3)
Fibrinogen Studies C, Wood AM, White I, Thompson SG, Lewington S, Danesh J. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol. 2006;35(6):1570–8. https://doi.org/10.1093/ije/dyl233 . (PMID: 10.1093/ije/dyl233)
Rosner B, Willett WC, Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med. 1989;8(9):1051–69. discussion 1071-1053. (PMID: 10.1002/sim.47800809052799131)
Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001. (PMID: 10.1007/978-1-4757-3462-1)
Kunutsor SK, Laukkanen JA. Gamma-glutamyltransferase and risk of chronic kidney disease: a prospective cohort study. Clin Chim Acta. 2017;473:39–44. https://doi.org/10.1016/j.cca.2017.08.014 . (PMID: 10.1016/j.cca.2017.08.01428811239)
Groenwold RH, Klungel OH, Grobbee DE, Hoes AW. Selection of confounding variables should not be based on observed associations with exposure. Eur J Epidemiol. 2011;26(8):589–93. https://doi.org/10.1007/s10654-011-9606-1 . (PMID: 10.1007/s10654-011-9606-1217964193168755)
Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928–35. (PMID: 10.1161/CIRCULATIONAHA.106.67240217309939)
Harrell FEJ. Regression modeling strategies. New York: Springer; 2001. (PMID: 10.1007/978-1-4757-3462-1)
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72; discussion 207-112. https://doi.org/10.1002/sim.2929 . (PMID: 10.1002/sim.292917569110)
Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21. https://doi.org/10.1002/sim.4085 . (PMID: 10.1002/sim.408521204120)
Ren X, Jiang M, Han L, Zheng X. Association between triglyceride-glucose index and chronic kidney disease: a cohort study and meta-analysis. Nutr Metab Cardiovasc Dis. 2023;33(6):1121–8. https://doi.org/10.1016/j.numecd.2023.03.026 . (PMID: 10.1016/j.numecd.2023.03.02637088649)
Meza CA, La Favor JD, Kim DH, Hickner RC. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? Int J Mol Sci. 2019;20(15) https://doi.org/10.3390/ijms20153775 .
Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019;21(1) https://doi.org/10.3390/ijms21010263 .
Perlstein TS, Gerhard-Herman M, Hollenberg NK, Williams GH, Thomas A. Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol. 2007;18(3):944–51. https://doi.org/10.1681/ASN.2006091026 . (PMID: 10.1681/ASN.200609102617287426)
فهرسة مساهمة: Keywords: Chronic kidney disease; Cohort study; Triglyceride-glucose index
المشرفين على المادة: IY9XDZ35W2 (Glucose)
0 (Triglycerides)
0 (Blood Glucose)
تواريخ الأحداث: Date Created: 20240105 Date Completed: 20240415 Latest Revision: 20240722
رمز التحديث: 20240722
مُعرف محوري في PubMed: PMC11009217
DOI: 10.1007/s11357-023-01044-5
PMID: 38180700
قاعدة البيانات: MEDLINE
الوصف
تدمد:2509-2723
DOI:10.1007/s11357-023-01044-5